|
2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol |
|---|---|
| Trade Name | Epidiolex |
| Orphan Indication | Lennox-Gastaut syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2014-02-27 00:00:00 |
| Sponsor | GW Pharma Ltd.;Porton Down Science Park, Salisbury, Wiltshire SP4 OJQ; |
